How should oral ofloxacin be administered, including dose, duration, food considerations, and dose adjustment for renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Administer Oral Ofloxacin

Oral ofloxacin should be administered at 200-400 mg every 12 hours depending on the infection type, taken without regard to meals, with dose reduction required when creatinine clearance falls below 50 mL/min. 1

Standard Dosing by Indication

The dose varies significantly based on the specific infection being treated 1:

Common Infections:

  • Uncomplicated gonorrhea: 400 mg as a single dose 2
  • Spontaneous bacterial peritonitis (SBP): 400 mg twice daily for 8 days (in hospitalized patients without vomiting, shock, grade II or higher hepatic encephalopathy, or serum creatinine ≥3 mg/dL) 3
  • Respiratory infections (acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia): 400 mg every 12 hours for 10 days 1
  • Uncomplicated cystitis (E. coli or K. pneumoniae): 200 mg every 12 hours for 3 days 1
  • Uncomplicated cystitis (other pathogens): 200 mg every 12 hours for 7 days 1
  • Complicated UTIs: 200 mg every 12 hours for 10 days 1
  • Prostatitis (E. coli): 300 mg every 12 hours for 6 weeks 1
  • Acute pelvic inflammatory disease: 400 mg every 12 hours for 10-14 days 1

Food Considerations

Ofloxacin can be taken without regard to meals 1. While food slightly delays absorption (prolonged Tmax), it does not significantly affect the total amount absorbed (Cmax and AUC are minimally reduced but not clinically relevant) 4. Administration with meals may improve gastrointestinal tolerability 1.

Critical Drug Interactions

Do not administer ofloxacin within 2 hours before or 2 hours after the following agents, as they significantly impair absorption 1:

  • Antacids containing calcium, magnesium, or aluminum
  • Sucralfate
  • Iron supplements
  • Multivitamins containing zinc
  • Didanosine (chewable/buffered tablets or pediatric powder)

Renal Dose Adjustment

Dose adjustment is mandatory when creatinine clearance is ≤50 mL/min 1:

Creatinine Clearance Maintenance Dose Frequency
>50 mL/min Standard dose Every 12 hours
20-50 mL/min Standard unit dose Every 24 hours
<20 mL/min Half the standard unit dose Every 24 hours

Important considerations for renal impairment:

  • Give a normal initial loading dose, then adjust maintenance dosing 1
  • The half-life increases dramatically in severe renal failure (from ~5 hours to ~23 hours) 5
  • Renal clearance correlates directly with creatinine clearance 5, 6
  • Ofloxacin is minimally removed by hemodialysis (~50% dialysance of creatinine), so timing relative to dialysis is not critical 5

To estimate creatinine clearance when only serum creatinine is known 1:

For men: CrCl = [(140 - age) × weight in kg] / (72 × serum creatinine in mg/dL)

For women: 0.85 × the value calculated for men

Hepatic Impairment

In patients with severe liver dysfunction (cirrhosis with or without ascites), do not exceed 400 mg per day 1. Ofloxacin excretion may be reduced in these patients.

Pharmacokinetic Profile

Understanding ofloxacin's pharmacokinetics helps optimize dosing 1:

  • Bioavailability: ~98% after oral administration
  • Time to peak concentration: 1-2 hours
  • Half-life: 4-5 hours (normal renal function); up to 23 hours in severe renal impairment
  • Protein binding: ~32%
  • Elimination: 65-80% excreted unchanged in urine; <5% as metabolites
  • Tissue penetration: Achieves 0.8-1.5 times concurrent plasma levels in most tissues

Common Pitfalls to Avoid

  1. Failing to adjust dose in renal impairment: This is the most critical error. Always calculate creatinine clearance and adjust accordingly 1, 7

  2. Co-administering with divalent/trivalent cations: The 2-hour separation window must be strictly observed 1

  3. Using in patients with prior quinolone exposure for SBP: Patients previously on quinolone prophylaxis may harbor resistant organisms and should receive alternative therapy (e.g., cefotaxime) 3

  4. Inappropriate use in critically ill patients: For SBP, oral ofloxacin is only appropriate in stable patients without vomiting, shock, severe encephalopathy, or significant renal dysfunction 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.